| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |